181 related articles for article (PubMed ID: 2807735)
41. Incorporation of a potentially helix breaking D-Phe-Pro sequence into the center of a right handed 16 residue peptide helix.
Gurunath R; Balaram P
Biochem Biophys Res Commun; 1994 Jul; 202(1):241-5. PubMed ID: 8037717
[TBL] [Abstract][Full Text] [Related]
42. Homooligopeptides composed of hydrophobic amino acid residues interact in a specific manner by taking alpha-helix or beta-structure toward lipid bilayers.
Lee S; Yoshitomi H; Morikawa M; Ando S; Takiguchi H; Inoue T; Sugihara G
Biopolymers; 1995 Sep; 36(3):391-8. PubMed ID: 7669922
[TBL] [Abstract][Full Text] [Related]
43. Regularly alternating L,D-peptides. III. Hexacyclic peptides from valine or phenylalanine.
Pavone V; Benedetti E; Di Blasio B; Lombardi A; Pedone C; Tomasich L; Lorenzi GP
Biopolymers; 1989 Jan; 28(1):215-23. PubMed ID: 2720106
[TBL] [Abstract][Full Text] [Related]
44. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
Flouret G; Chaloin O; Borovickova L; Slaninová J
J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
[TBL] [Abstract][Full Text] [Related]
45. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
46. Vibrational circular dichroism and IR spectral analysis as a test of theoretical conformational modeling for a cyclic hexapeptide.
Bour P; Kim J; Kapitan J; Hammer RP; Huang R; Wu L; Keiderling TA
Chirality; 2008 Nov; 20(10):1104-19. PubMed ID: 18506832
[TBL] [Abstract][Full Text] [Related]
47. Conformational studies of cyclo(L-Phe-L-Pro-Gly-L-Pro)2 by 13C nuclear magnetic resonance.
Ishizu T; Fujii A; Noguchi S
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1617-9. PubMed ID: 1934186
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and conformational studies of novel cyclic peptides constrained into a 3 10 helical structure by a heterochiral D-pro-L-pro dipeptide template.
Rao IN; Boruah A; Kumar SK; Kunwar AC; Devi AS; Vyas K; Ravikumar K; Iqbal J
J Org Chem; 2004 Mar; 69(6):2181-4. PubMed ID: 15058968
[TBL] [Abstract][Full Text] [Related]
49. Cyclic peptide models of the Ca2+-binding loop of alpha-lactalbumin.
Farkas V; Vass E; Hanssens I; Majer Z; Hollósi M
Bioorg Med Chem; 2005 Sep; 13(17):5310-20. PubMed ID: 16046135
[TBL] [Abstract][Full Text] [Related]
50. Stylissamides E and F, cyclic heptapeptides from the caribbean sponge Stylissa caribica.
Cychon C; Köck M
J Nat Prod; 2010 Apr; 73(4):738-42. PubMed ID: 20349940
[TBL] [Abstract][Full Text] [Related]
51. [Cyclic analogs of substance P. III. Cyclo (6(sup)gamma----oligomethylenediamine----11) substance P(6-11)-hexapeptides].
Mutulis FK; Mutule IE; Maurops GKh; Bergmann Iu; Myshliakova NV; Strazda GM; Liepin'sh EE; Saulitis IuB; Grigor'eva VD; Balodis IuIu
Bioorg Khim; 1991 Oct; 17(10):1412-23. PubMed ID: 1725106
[TBL] [Abstract][Full Text] [Related]
52. Two new minor cyclopeptides from Sagina japonica (Caryophyllaceae).
Jia AQ; Tan NH; Zhou J
Fitoterapia; 2009 Apr; 80(3):192-5. PubMed ID: 19535020
[TBL] [Abstract][Full Text] [Related]
53. The effect of the isomers of cyclo(Trp-Pro) on heart and ion-channel activity.
Jamie H; Kilian G; Dyason K; Milne PJ
J Pharm Pharmacol; 2002 Dec; 54(12):1659-65. PubMed ID: 12542896
[TBL] [Abstract][Full Text] [Related]
54. Cyclic peptides. VI. Asymmetric hydrogenation of dehydroalanine or dehydroaminobutanoic acid residue in cyclodipeptides.
Lee S; Kanmera T; Aoyagi H; Izumiya N
Int J Pept Protein Res; 1979 Feb; 13(2):207-17. PubMed ID: 429097
[TBL] [Abstract][Full Text] [Related]
55. Click chemistry as a route to cyclic tetrapeptide analogues: synthesis of cyclo-[Pro-Val-psi(triazole)-Pro-Tyr].
Bock VD; Perciaccante R; Jansen TP; Hiemstra H; van Maarseveen JH
Org Lett; 2006 Mar; 8(5):919-22. PubMed ID: 16494474
[TBL] [Abstract][Full Text] [Related]
56. Mimicry of beta II'-turns of proteins in cyclic pentapeptides with one and without D-amino acids.
Weisshoff H; Präsang C; Henklein P; Frömmel C; Zschunke A; Mügge C
Eur J Biochem; 1999 Feb; 259(3):776-88. PubMed ID: 10092864
[TBL] [Abstract][Full Text] [Related]
57. Cyclols, cyclodepsipeptides, and N-acyl-diketopiperazines from linear precursors. Synthesis and crystal structure of 10-membered cyclodepsipeptides.
Zanotti G; Pinnen F; Lucente G; Cerrini S; Gavuzzo E; Mazza F
Int J Pept Protein Res; 1983 Oct; 22(4):410-21. PubMed ID: 6654588
[TBL] [Abstract][Full Text] [Related]
58. Conformations of cyclo(L-orD-Phe-L-Pro-Aca) and cyclo(L-Pro-L- or D-Phe-Aca). Cyclized dipeptide models for specific types of beta-bends.
Mizuno H; Lee S; Nakamura H; Kodera Y; Kato T; Go N; Izumiya N
Biophys Chem; 1986 Nov; 25(1):73-90. PubMed ID: 3814747
[TBL] [Abstract][Full Text] [Related]
59. Conformational studies of cyclo(L-Phe-L-Pro-Gly-L-Pro)2 by 1H- and 13C-nuclear magnetic resonance spectroscopy, and its enantioface-differentiating ability.
Ishizu T; Fujii A; Noguchi S
Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):235-8. PubMed ID: 8500196
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis, and modeling of novel cyclic thrombin receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence with fixed conformations of pharmacophoric groups: importance of a Phe/Arg/NH2 cluster for receptor activation and implications in the design of nonpeptide thrombin receptor mimetics.
Alexopoulos K; Panagiotopoulos D; Mavromoustakos T; Fatseas P; Paredes-Carbajal MC; Mascher D; Mihailescu S; Matsoukas J
J Med Chem; 2001 Feb; 44(3):328-39. PubMed ID: 11462974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
